← Leaderboards
Russell N Van Gelder
Washington University
$16,133,253
Attributed
$20,138,521
Total exposure
13
Grants
11
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.1M · FY2005–25$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$20,138,521 · 13
By mechanism
R01$8,203,981 · 4
R24$6,057,778 · 1
U24$2,236,328 · 1
R42$1,701,925 · 1
R21$917,537 · 2
K08$552,935 · 1
Top collaborators
- King-Wai Yau6 shared
- Valery I Shestopalov5 shared
- Espoir Kyubwa2 shared
- Edmund Tsui1 shared
Most similar at Washington University
Same institution · by research overlap
- Rajendra S Apte$5,529,164
- David Delmar Limbrick$7,508,280
- Thomas Almon Ferguson$14,111,334
- Kevin D Moeller$3,324,742
- Kendall Jay Blumer$18,625,201
Others in their field
Top investigators on “Laboratories”
- David Heimbrook · Leidos Biomedical Research, Inc.$943,075,715
- Lawrence Corey · Fred Hutchinson Cancer Center$747,603,944
- Jeffrey P Krischer · University Of South Florida$627,303,958
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$553,634,937
- Bambra Strokes · Ppd Development Lp$526,656,217
- Leonard Freedman · Leidos Biomedical Research, Inc.$463,311,620
Research focus
LaboratoriesSamplingBlindnessCircadian RhythmsResponsePhotoreceptorsCatalogsTissuesOcular SurfaceData SetVirusLightPathogenEye DiseasesVisualMetagenomicsMicrobialGenesGenomicsSwabClinical ResearchOrganismFutureHour
Grant awards (44)
NGS based metagenomic screening of ocular infections$898,365
R42 · FY2025 · EY
Determinants of the periocular microbiome$369,464
U24 · FY2025 · EY · contact PI
Determinants of the periocular microbiome$205,013
U24 · FY2025 · EY · contact PI
Determinants of the periocular microbiome$61,740
U24 · FY2025 · EY · contact PI
Determinants of the periocular microbiome$804,244
U24 · FY2024 · EY · contact PI
NGS based metagenomic screening of ocular infections$803,560
R42 · FY2024 · EY
Determinants of the periocular microbiome$795,867
U24 · FY2023 · EY · contact PI
Molecular determinants of pathogenicity in viral conjunctivitis$256,808
R21 · FY2022 · EY · contact PI
Functions of OPN5 and OPN3 in the eye$536,170
R01 · FY2021 · EY · contact PI
Molecular determinants of pathogenicity in viral conjunctivitis$220,625
R21 · FY2021 · EY · contact PI
Functions of OPN5 and OPN3 in the eye$564,302
R01 · FY2020 · EY · contact PI
Functions of OPN5 and OPN3 in the eye$575,459
R01 · FY2019 · EY · contact PI
Photoswitchable channel blockers for treatment of blindness$1,211,406
R24 · FY2018 · EY · contact PI
Functions of OPN5 and OPN3 in the eye$577,295
R01 · FY2018 · EY · contact PI
Molecular epidemiology of adenoviral pathogenesis in keratoconjunctivitis$220,104
R21 · FY2018 · EY · contact PI
Functions of OPN5 and OPN3 in the eye$88,706
R01 · FY2018 · EY · contact PI
Photoswitchable channel blockers for treatment of blindness$1,150,477
R24 · FY2017 · EY · contact PI
Functions of OPN5 and OPN3 in the eye$480,006
R01 · FY2017 · EY · contact PI
Molecular epidemiology of adenoviral pathogenesis in keratoconjunctivitis$220,000
R21 · FY2017 · EY · contact PI
Photoswitchable channel blockers for treatment of blindness$1,261,874
R24 · FY2016 · EY · contact PI
Diversity and Dynamic Stability of the Ocular Surface Microbiome$630,621
R01 · FY2016 · EY · contact PI
Photoswitchable channel blockers for treatment of blindness$979,534
R24 · FY2015 · EY · contact PI
Diversity and Dynamic Stability of the Ocular Surface Microbiome$621,453
R01 · FY2015 · EY · contact PI
Photoswitchable channel blockers for treatment of blindness$1,454,487
R24 · FY2014 · EY · contact PI
Diversity and Dynamic Stability of the Ocular Surface Microbiome$647,740
R01 · FY2014 · EY · contact PI
Diversity and Dynamic Stability of the Ocular Surface Microbiome$630,276
R01 · FY2013 · EY · contact PI
Diversity and Dynamic Stability of the Ocular Surface Microbiome$657,129
R01 · FY2012 · EY · contact PI
MECHANISMS OF LIGHT-MEDIATED PROTEIN DEGRADATION$231,660
R01 · FY2010 · GM · contact PI
MECHANISMS OF LIGHT-MEDIATED PROTEIN DEGRADATION$234,000
R01 · FY2009 · GM · contact PI
A TRANSGENIC MODEL OF OCULAR INFLAMMATION$5,825
P41 · FY2009 · RR · contact PI
MECHANISMS OF LIGHT-MEDIATED PROTEIN DEGRADATION$234,000
R01 · FY2008 · GM · contact PI
A TRANSGENIC MODEL OF OCULAR INFLAMMATION$11,239
P41 · FY2008 · RR · contact PI
A transgenic model of ocular inflammation$148,568
R03 · FY2007 · EY · contact PI
Cryptochrome function in non-visual photoreception$347,743
R01 · FY2006 · EY · contact PI
A transgenic model of ocular inflammation$149,405
R03 · FY2006 · EY · contact PI
Cryptochrome function in non-visual photoreception$25,768
R01 · FY2006 · EY · contact PI
Cryptochrome function in non-visual photoreception$382,500
R01 · FY2005 · EY
A transgenic model of ocular inflammation$153,000
R03 · FY2005 · EY
Cryptochrome function in non-visual photoreception$362,694
R01 · FY2004 · EY
Cryptochrome function in non-visual photoreception$376,459
R01 · FY2003 · EY
FUNCTION OF CRYPTOCHROMES IN THE EYE$139,971
K08 · FY2003 · EY
FUNCTION OF CRYPTOCHROMES IN THE EYE$139,905
K08 · FY2002 · EY
FUNCTION OF CRYPTOCHROMES IN THE EYE$138,812
K08 · FY2001 · EY
FUNCTION OF CRYPTOCHROMES IN THE EYE$134,247
K08 · FY2000 · EY